Abstract
The objective of this work was to assess the therapeutic efficacy and to lerability of intravenously applied n-3-PUFA in patients with active rheumatoid arthritis (RA). Thirty-four patients with active RA [identified as having a DAS28 (disease activity score including a 28 joint count) >4.0] were enrolled into this 5-wk open pilot study (one group design). From the time of screening (visit 0, or V0), background therapy had to remain unchanged. Patients received 2 mL/kg(=0.1–0.2 g fish oil/kg) fish oil emulsion intravenously on 7 consecutive days (Visit 1–Visit 2, or V1–V2) in addition to their background therapy. A decrease of the DAS28>0.6 at day 8 (Visit 2) was the primary efficacy measure. Moreover, the DAS28 at day 35 (Visit 3, or V3), the modified Health Assessment Questionnaire, the American College of Rheumatology (ACR) response criteria (V2, V3) and the Short Form-36 (V3) were assessed. Thirty-three patients completed the trial. The mean DAS28 at V1 was 5.45; at V2, 4.51 (P<.001 V1–V2) and at V3, 4.73 (P<.001 V1–V3; V2–V3, not significantly different). Of the 34 patients, 56% achieved a reduction of the DAS28>0.6 at V2 (mean 1.52); 27%>1.2. At V3, 41% of the patients showed a DAS28 reduction >0.6 (mean 1.06), and 36%>1.2. ACR 20 and 50% responses at V2 were seen in 29 and 12% of patients, respectively; at V3, the comparable values were 18 and 9%, respectively. Overall tolerability was excellent. Intravenous application of n-3-PUFA (as an add-on therapy) was considerably well tolerated and led to improvement of the disease activity status in a reasonable number of RA patients. Future trials are warranted to answer whether the intravenous application of n-3-PUFA constitutes a therapeutic option in RA patients.
Similar content being viewed by others
Abbreviations
- ACR:
-
American College of Rheumatology
- BMI:
-
body mass index
- CRP:
-
C-reactive protein
- DAS28:
-
disease activity score including a 28-joint count
- DMARD:
-
disease-modifying antirheumatic drug(s)
- ESR:
-
erythrocyte sedimentation rate
- EULAR:
-
European League Against Rheumatism
- EULARC:
-
EULAR response criteria
- ITT:
-
intent-to-treat
- M-HAQ:
-
modified health assessment questionnaire
- NS:
-
not significantly different
- NSAID:
-
nonsteroidal antirheumatic drug(s)
- RA:
-
rheumatoid arthritis
- RF:
-
IgM-rheumatoid factor
- SF-36:
-
Medical Outcomes Study Short Form 36
- SJC:
-
swollen joint count
- TJC:
-
tender joint count
- V0:
-
screening visit
- V1:
-
study entry visit
- V2:
-
visit after 1 wk
- V3:
-
final visit (4 wk after application of PUFA)
- VAS:
-
visual analog scale
- VAS-GH:
-
visual analog scale of patient's general health
- VAS pain:
-
visual analog scale of patient's pain
- VAS ph:
-
visual analog scale of physician's global assessment
References
Shapiro, J.A., Koepsell, T., Voight, L.F., Dugowson, C.E., Kestin, M., and Nelson, J.L. (1996) Diet and Rheumatoid Arthritis in Women: A Possible Protective Effect of Fish Consumption. Epidemiology 7, 256–263.
Linos, A., Kaklamanis, E., Kontomerkos, A., Koumantaki, Y., Gazi, S., Vaiopoulos, G., Tsokos, G.C., and Kaklamanis, P. (1991) The Effect of Olive Oil and Fish Consumption on Rheumatoid Arthritis: A Case Control Study. Scand. J. Rheumatol. 20, 419–426.
Linos, A., Kaklamani, V.G., Kaklamani, E., Koumantaki, Y., Giziaki, E., Papazoglou, S., and Mantzoros, C.S. (1999) Dietary Factors in Relation to Rheumatoid Arthritis: A Role for Olive Oil and Cooked Vegetables? Am. J. Clin. Nutr. 70, 1077–1082.
Recht, L., Helin, P., Rasmussen, J.O., Jacobsen, J., Lithman, T., and Scherstén, B. (1990) Hand Handicap and Rheumatoid Arthritis in a Fish-Eating Society (the Faroe Islands). J. Intern. Med. 227, 49–55.
Drosos, A.A., Alamanos, I., Voulgari, P.V., Psychos, D.N., Katsaraki, A., Papadopoulos, I., Dimou, G., and Siozos, C. (1997) Epidemiology of Adult Rheumatoid Arthritis in Northwest Greece 1987–1995. J. Rheumatol. 24, 2129–2133.
Calder, P.C. (2002) Dietary Modification of Inflammation with Lipids, Proc. Nutr. Soc. 6, 345–358.
Kremer, J.M., Lawrence, D.A., Jubiz, W., DiGiacomo, R., Rynes, R., Bartholomew, L.E., and Sherman, M. (1990) Dietary Fish Oil and Olive Oil Supplementation in Patients with Rheumatoid Arthritis. Clinical and Immunologic Effects, Arthritis Rheum. 33, 810–820.
Trichopoulou, A., and Vasilopoulou, E. (2000) Mediterranean Diet and Longevity, Br. J. Nutr. (Suppl. 2), 205–209.
de Lorgeril, M., Renaud, S., Salen, P., Monjaud, I., Mamelle, N., Martin, J.-L., Guidollet, J., Touboul, P., and Delaye, J. (1994) Mediterranean α-Linolenic Acid Rich Diet in Secondary Prevention of Coronary Heart Disease. Lancet 343, 1454–1459.
Cleland, L.G., and James, M.J. (2000) Fish Oil and Rheumatoid Arthritis: Antiinflammatory and Collateral Health Benefits. J. Rheumatol. 27, 2305–2307.
Arnett, F.C., Edwarthy, S.M., Bloch, D.A., McShane, D.J., Fries, D.J., Cooper, N.S., Healey, L.A., Kaplan, S.R., Liang, M.H., Luthra, H.S., et al. (1988) The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis Rheum. 31, 315–324.
Prevoo, M.L., van't Hof, M.A., Kuper, H.H., van Leeuwen, M.A., van de Putte, L.B., and van Riel, P.L. (1995) Modified Disease Activity Scores That Include Twenty-Eight-Joint Counts. Development and Validation in a Prospective Longitudinal Study of Patients with Rheumatoid Arthritis. Arthritis Rheum. 38, 44–48.
Van Gestel, A.M., and Prevoo, M.L., van't Hof, M.A., van Rijswijk M.H., van de Putte L.B., van Riel, P.L.C.M., (1996) Development and Validation of the European League Against Rheumatism Response Criteria for Rheumatoid Arthritis. Comparison with the Preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum. 39, 34–40.
Felson, D.T., Anderson, J.J., Boers, M., Bombardier, C., Furst, D.E., Goldsmith, C., Katz, L.M., Lightfoot, R., Jr. Paulus, H., Strand, V., et al. (1995) American College of Rheumatology. Preliminary Definition of Improvement in Rheumatoid Arthritis. Arthritis Rheum. 38, 727–735.
Pincus, T., Summey, J.A., Soraci, S.A., Jr., Wallston, K.A., and Hummon, N.P. (1983) Assessment of Patient Satisfaction in Activities of Daily Living Using a Modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 26, 1346–1353.
Garratt, A.M., Ruta, D.A., Abdalla, M.I., Buckingham, J.K., and Russell, I.T. (1993) The SF-36 Health Survey Questionnaire: An Outcome Measure Suitable for Routine Use Within the NHS? Br. Med. J. 306, 1440–1444.
Cleland, L.G., James, M.J., and Proudman, S.M. (2003) The Role of Fish Oils in the Treatment of Rheumatoid Arthritis, Drugs 63, 845–853.
Steinmetz, A. (2003) Treatment of Diabetic Dyslipoproteinemia, Exp. Clin. Endocrinol. Diabetes 111, 239–245.
Adam, O., Beringer, C., Kless, T., Lemmen, C., Adam, A., Wiseman, M., Adam, P., Klimmek, R., and Forth, W. (2003) Anti-inflammatory Effects of a Low Arachidonic Acid Diet and Fish Oil in Patients with Rheumatoid Arthritis. Rheumatol. Int. 23, 27–36.
Sköldstam, L., Hagfors, L., and Johansson, G. (2003) An Experimental Study of a Mediterranean Diet Intervention for Patients with Rheumatoid Arthritis. Ann. Rheum. Dis. 62, 208–214.
Leeb, B.F., Andel, I., Leder, S., Leeb, B.A., and Rintelen, B. (2005) The Patient's Perspective and Rheumatoid Arthritis Disease Activity Indexes. Rheumatology (Oxford) 44, 360–365, 569.
Kingsley, G.H., Khoshaba, B., Smith, C.M., Choy, E.H., and Scott, D.L. (2005) Are Clinical Trials in Rheumatoid Arthritis Generalizable to Routine Practice? A Re-evaluation of Trial Entry Criteria. Rheumatology (Oxford) 44, 629–632.
Maini, R., St. Clair, E.W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) Versus Placebo in Rheumatoid Arthritis Patients Receiving Concomitant Methotrexate: A Randomised Phase III Trial, Lancet 354, 1932–1939.
Bresnihan, B., Alvaro-Gracia, J.M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) Treatment of Rheumatoid Arthritis with Recombinant Human Interleukin-1 Receptor Antagonist, Arthritis Rheum, 41, 2196–2204.
James, M.J., and Cleland, L.G. (1997) Dietary n-3 Fatty Acids and Therapy for Rheumatoid Arthritis. Semin. Arthritis Rheum. 27, 85–97.
Greenwood, M.C., Doyle, D.V., and Ensor, M. (2001) Does the Stanford Health Assessment Questionnaire Have Potential as a Monitoring Tool for Subjects with Rheumatoid Arthritis? Ann. Rheum. Dis. 60, 344–348.
Volker, D., Fitzgerald, P., Major, G., and Garg, M. (2000) Efficacy of Fish Oil Concentrate in the Treatment of Rheumatoid Arthritis, J. Rheumatol. 27, 2343–2346.
Kremer, J.M., Lawrence, D.A., Petrillo, G.F., Litts, L.L., Mullaly, P.M., Rynes, R.I., Stocker, R.P., Parhami, N., Greenstein, N.S., Fuchs, B.R., et al. (1995) Effects of High-Dose Fish Oil on Rheumatoid Arthritis After Stopping Nonsteroidal Antiinflammatory Drugs. Clinical and Immune Correlates, Arthritis Rheum. 38, 1107–1114
Wolfram, G. (2003) Dietary Fatty Acids and Coronary Heart Disease, Eur. J. Med. Res. 8, 321–324.
Maini, R.N., Breedveld, F.C., Kalden, J.R., Smolen, J.S., Davis, D., Macfarlane, J.D., Antoni, C., Leeb, B., Elliott, M.J., Woody, J.N. et al. (1998) Therapeutic Efficacy of Multiple Intravenous Infusions of Anti-tumor Necrosis Factor Alpha Monoclonal Antibody Combined with Low-Dose Weekly Methotrexate in Rheumatoid Arthritis, Arthritis Rheum. 41, 1552–1563.
O'Dell, J.R. (2004) Therapeutic Strategies for Rheumatoid Arthritis, N. Engl. J. Med. 350, 2591–2602.
Fassl, C., Sautner, J., Rintelen, B., and Leeb, B.F. (2005) Intravenous Application of Omega-3 Fatty Acids in a Patient with Active Spondylarthropathy-A Case Report, Clin. Rheumatol., October 12 [Epub ahead of print].
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Leeb, B.F., Sautner, J., Andel, I. et al. Intravenous application of omega-3 fatty acids in patients with active rheumatoid arthritis. The ORA-1 trial. An open pilot study. Lipids 41, 29–34 (2006). https://doi.org/10.1007/11745-006-5066-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/11745-006-5066-x